xtt cell proliferation assay kit Search Results


95
ATCC xtt cell proliferation assay kit
Xtt Cell Proliferation Assay Kit, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtt cell proliferation assay kit/product/ATCC
Average 95 stars, based on 1 article reviews
xtt cell proliferation assay kit - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

90
Merck KGaA xtt cell proliferation kit ii
Xtt Cell Proliferation Kit Ii, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtt cell proliferation kit ii/product/Merck KGaA
Average 90 stars, based on 1 article reviews
xtt cell proliferation kit ii - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Applichem inc cell proliferation kit xtt
Cell Proliferation Kit Xtt, supplied by Applichem inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell proliferation kit xtt/product/Applichem inc
Average 90 stars, based on 1 article reviews
cell proliferation kit xtt - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
SERVA Electrophoresis xtt cell proliferation assay kit
Cytocompatibility of silk fibroin films: Left : <t>XTT</t> assay for cell viability and <t>proliferation</t> of L929 cells cultivated on films from silk fibroin for 24 h, 48 h, and 72 h, respectively. The mean cell metabolic activity and standard error of the mean are reported for three independent silk fibroin samples dissolved with ZnCl 2 in triplicates. Right : Representative fluorescence microscopy image of live-dead staining of L929 cells after 72 h cultivated on films from silk fibroin dissolved in ZnCl 2 .
Xtt Cell Proliferation Assay Kit, supplied by SERVA Electrophoresis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtt cell proliferation assay kit/product/SERVA Electrophoresis
Average 90 stars, based on 1 article reviews
xtt cell proliferation assay kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Cayman Chemical xtt cell proliferation assay kit
(A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. <t>(G)</t> <t>Viability</t> of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using <t>XTT</t> assay.
Xtt Cell Proliferation Assay Kit, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtt cell proliferation assay kit/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
xtt cell proliferation assay kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
PanReac AppliChem xtt cell proliferation assessment kit
(A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. <t>(G)</t> <t>Viability</t> of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using <t>XTT</t> assay.
Xtt Cell Proliferation Assessment Kit, supplied by PanReac AppliChem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtt cell proliferation assessment kit/product/PanReac AppliChem
Average 90 stars, based on 1 article reviews
xtt cell proliferation assessment kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Abnova xtt cell proliferation assay kit
(A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. <t>(G)</t> <t>Viability</t> of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using <t>XTT</t> assay.
Xtt Cell Proliferation Assay Kit, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtt cell proliferation assay kit/product/Abnova
Average 90 stars, based on 1 article reviews
xtt cell proliferation assay kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Promega xtt-based cell proliferation kit ii
(A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. <t>(G)</t> <t>Viability</t> of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using <t>XTT</t> assay.
Xtt Based Cell Proliferation Kit Ii, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtt-based cell proliferation kit ii/product/Promega
Average 90 stars, based on 1 article reviews
xtt-based cell proliferation kit ii - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
MD Biosciences xtt cell proliferation kit
(A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. <t>(G)</t> <t>Viability</t> of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using <t>XTT</t> assay.
Xtt Cell Proliferation Kit, supplied by MD Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtt cell proliferation kit/product/MD Biosciences
Average 90 stars, based on 1 article reviews
xtt cell proliferation kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Biomol GmbH colorimetric xtt cell viability and proliferation kit
(A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. <t>(G)</t> <t>Viability</t> of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using <t>XTT</t> assay.
Colorimetric Xtt Cell Viability And Proliferation Kit, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/colorimetric xtt cell viability and proliferation kit/product/Biomol GmbH
Average 90 stars, based on 1 article reviews
colorimetric xtt cell viability and proliferation kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
HiMedia Laboratories cell proliferation kit ii (xtt)
(A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. <t>(G)</t> <t>Viability</t> of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using <t>XTT</t> assay.
Cell Proliferation Kit Ii (Xtt), supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell proliferation kit ii (xtt)/product/HiMedia Laboratories
Average 90 stars, based on 1 article reviews
cell proliferation kit ii (xtt) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Cosmo Bio USA xtt cell proliferation assay kit
(A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. <t>(G)</t> <t>Viability</t> of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using <t>XTT</t> assay.
Xtt Cell Proliferation Assay Kit, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtt cell proliferation assay kit/product/Cosmo Bio USA
Average 90 stars, based on 1 article reviews
xtt cell proliferation assay kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Cytocompatibility of silk fibroin films: Left : XTT assay for cell viability and proliferation of L929 cells cultivated on films from silk fibroin for 24 h, 48 h, and 72 h, respectively. The mean cell metabolic activity and standard error of the mean are reported for three independent silk fibroin samples dissolved with ZnCl 2 in triplicates. Right : Representative fluorescence microscopy image of live-dead staining of L929 cells after 72 h cultivated on films from silk fibroin dissolved in ZnCl 2 .

Journal: International Journal of Molecular Sciences

Article Title: A Fast and Reliable Process to Fabricate Regenerated Silk Fibroin Solution from Degummed Silk in 4 Hours

doi: 10.3390/ijms221910565

Figure Lengend Snippet: Cytocompatibility of silk fibroin films: Left : XTT assay for cell viability and proliferation of L929 cells cultivated on films from silk fibroin for 24 h, 48 h, and 72 h, respectively. The mean cell metabolic activity and standard error of the mean are reported for three independent silk fibroin samples dissolved with ZnCl 2 in triplicates. Right : Representative fluorescence microscopy image of live-dead staining of L929 cells after 72 h cultivated on films from silk fibroin dissolved in ZnCl 2 .

Article Snippet: The XTT Cell Proliferation Assay Kit (Serva, Heidelberg, Germany) was used to quantitatively evaluate cell metabolic activity according to the manufacturer’s protocol after 24, 48, and 72 h, respectively.

Techniques: XTT Assay, Activity Assay, Fluorescence, Microscopy, Staining

(A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. (G) Viability of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using XTT assay.

Journal: bioRxiv

Article Title: Therapeutic reversal of prenatal pontine ID1 signaling in DIPG

doi: 10.1101/2021.05.10.443452

Figure Lengend Snippet: (A) Western blot (WB) confirming ID1 knockdown in DIPG007 cells. (B) WB depicting reduction in SPARCL1 expression along with decreased ID1 expression in ID1 -knockdown DIPG007 cells. (C) Effect of ID1 knockdown on invasion as measured by Matrigel-coated Boyden chamber assay. Images show invading cells stained with crystal violet. Each data point represents an individual image; **P < 0.01, unpaired parametric t-test. (D-E) Effect of ID1 knockdown on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Images show representative scratch at 0 and 24 hours outlined in dotted red line. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.01; images taken with Incucyte; area measured by ImageJ. (F) WB for ID1 and ACTB expression in DIPG007 and PPK cells treated with increasing concentrations of CBD or DMSO control. (G) Viability of DIPG007 and PPK cells treated with increasing concentrations of CBD (0.5-20µM) relative to DMSO-treated control. Experiment was completed in triplicate and data points represent mean+/-SEM. (H) DIPG007 cells were treated for 2 days with DMSO (control), 2.5µM or 5µM CBD and invasion was measured by Matrigel-coated Boyden chamber. Each data point represents an individual image, mean+/-SEM; ****P < 0.0001, unpaired parametric t-test. (I) Effect of CBD treatment (5-10µM) on DIPG007 migration as measured by scratch assay, quantified as percent wound closure. Experiment was completed in triplicate and data points represent mean+/-SEM, **P < 0.005, two-way ANOVA t-test. (J) Histogram showing increase in DCF (ROS) with increasing doses of CBD. (K) Production of ROS mediates the inhibitory activity of CBD through ID1. DIPG007 cells were treated for 72 hours with vehicle (DMSO) or different concentrations of CBD (10, 8, 6, 4, 2, 1 µM) in the presence and absence of 50 µM TOC. IC 50 was 2.3µM for CBD treatment alone and 10.34µM for CBD + TOC; ****P < 0.0001, two-way ANOVA t-test. Cell proliferation was measured using XTT assay.

Article Snippet: After 72 hours, in vitro cell viability was monitored by XTT Cell Proliferation Assay kit (Cayman Chemical).

Techniques: Western Blot, Expressing, Boyden Chamber Assay, Staining, Migration, Wound Healing Assay, Activity Assay, XTT Assay